Brazil rolls out 20‑valent pneumococcal vaccine for children through SUS

The Ministry of Health launched the 20‑valent pneumococcal conjugate vaccine (Pneumo 20) on 20 June, making it available free of charge in the public Unified Health System (SUS) for children under five. The new immuniser protects against 20 serotypes of Streptococcus pneumoniae, expanding coverage beyond the previous 10‑valent formulation and also preventing otitis media and severe invasive disease.

Initial vaccinations were carried out in São Paulo’s Campo Limpo district, with the Ministry estimating about 2 million children will be immunised nationwide. Over 8 million doses have been purchased and more than 6 million are slated for distribution across states, including early shipments to Várzea Grande, Rio de Janeiro, São Luís, Amazonas, Mato Grosso and other municipalities. The schedule follows a transition scheme: a first dose of Pneumo 20 at two months, a second dose of Pneumo 10 at four months, and a booster of Pneumo 20 at twelve months. Children already completed on the older schedule remain protected and need no additional doses.

Health officials cite the vaccine’s broader serotype protection—especially types 3, 6A and 19A—as a means to cut hospitalisations, sequelae and mortality from pneumococcal pneumonia, meningitis and related infections, which accounted for over 4 600 cases and 1 400 deaths in Brazil between 2023‑2025. The rollout also includes priority groups such as elderly adults in long‑term care, indigenous peoples over five years without prior vaccination, and patients with chronic conditions.

The nationwide rollout is expected to reduce the financial burden on families and the SUS by lowering intensive‑care admissions and long‑term treatment costs associated with severe pneumococcal disease.